Drug intelligence / Profile preview

Softa-Man

Development stage: Unknown
Lead developer: B. Braun
Modality: Small Molecules
Administration: Topical

Overview

Softa-Man is an alcohol-based hand disinfectant solution used for hygienic and surgical hand antisepsis. It is a combination formulation typically containing 45% (w/w) ethanol and 18% (w/w) 1-propanol, supplemented with skin-protecting and conditioning ingredients such as panthenol and bisabolol to enhance dermal tolerability and prevent skin dryness. The product is designed to provide broad-spectrum antimicrobial activity against bacteria, fungi, and various viruses. Developed and manufactured by B. Braun, Softa-Man is primarily utilized in healthcare settings to ensure high standards of hand hygiene and to reduce the risk of cross-transmission of healthcare-associated infections.

Brand names: Softa-Man
Other names: Softa-Man ViscoRub

Beyond the preview

Go deeper on Softa-Man.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Softa-Man.

Explore the full profile